1 536

Cited 0 times in

Clopidogrel treatment and the MEND-CABG II trial

DC Field Value Language
dc.contributor.author강석민-
dc.contributor.author오재원-
dc.date.accessioned2015-05-19T16:26:09Z-
dc.date.available2015-05-19T16:26:09Z-
dc.date.issued2008-
dc.identifier.issn0098-7484-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/106300-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHCoronary Artery Bypass/adverse effects*-
dc.subject.MESHCoronary Artery Bypass/mortality-
dc.subject.MESHHumans-
dc.subject.MESHMyocardial Infarction/etiology*-
dc.subject.MESHMyocardial Infarction/prevention & control*-
dc.subject.MESHMyocardial Reperfusion Injury/etiology-
dc.subject.MESHMyocardial Reperfusion Injury/prevention & control-
dc.subject.MESHPlatelet Aggregation Inhibitors/therapeutic use*-
dc.subject.MESHPurinergic Antagonists*-
dc.subject.MESHPyridoxal Phosphate/therapeutic use*-
dc.subject.MESHRisk-
dc.subject.MESHTiclopidine/analogs & derivatives*-
dc.subject.MESHTiclopidine/therapeutic use-
dc.titleClopidogrel treatment and the MEND-CABG II trial-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorJaewon Oh-
dc.contributor.googleauthorNamki Hong-
dc.contributor.googleauthorSeok-Min Kang-
dc.identifier.doi10.1001/jama.300.9.1021-a-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00037-
dc.contributor.localIdA02395-
dc.relation.journalcodeJ01196-
dc.identifier.eissn1538-3598-
dc.identifier.pmid18768409-
dc.identifier.urlhttp://jama.jamanetwork.com/article.aspx?articleid=182490-
dc.subject.keywordCoronary Artery Bypass/adverse effects*-
dc.subject.keywordCoronary Artery Bypass/mortality-
dc.subject.keywordHumans-
dc.subject.keywordMyocardial Infarction/etiology*-
dc.subject.keywordMyocardial Infarction/prevention & control*-
dc.subject.keywordMyocardial Reperfusion Injury/etiology-
dc.subject.keywordMyocardial Reperfusion Injury/prevention & control-
dc.subject.keywordPlatelet Aggregation Inhibitors/therapeutic use*-
dc.subject.keywordPurinergic Antagonists*-
dc.subject.keywordPyridoxal Phosphate/therapeutic use*-
dc.subject.keywordRisk-
dc.subject.keywordTiclopidine/analogs & derivatives*-
dc.subject.keywordTiclopidine/therapeutic use-
dc.contributor.alternativeNameKang, Seok Min-
dc.contributor.alternativeNameOh, Jae Won-
dc.contributor.affiliatedAuthorKang, Seok Min-
dc.contributor.affiliatedAuthorOh, Jae Won-
dc.rights.accessRightsnot free-
dc.citation.volume300-
dc.citation.number9-
dc.citation.startPage1021-
dc.citation.endPage1022-
dc.identifier.bibliographicCitationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.300(9) : 1021-1022, 2008-
dc.identifier.rimsid56338-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.